Nautilus Biotechnology, Inc. NAUT
2.35 USD +0.02 (+0.64%)
At closeNov 3, 2026, 4:00 PM EST
2.29 -0.06 -2.55%
After hours · Nov 3, 4:00 PM ET
2.32 Day range 2.55
0.841 52-week range 4.31
- YTD
- +20.51%
- 1 year
- +27.03%
Financial health
Altman Z-Score
1.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -4.1×
FY 2018 5y median -4.1× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.6×
FY 2018 5y median 1.2× FY 2025
P/FCF -4.7×
FY 2018 5y median -4.7× FY 2025
EV/EBITDA -5.0×
FY 2018 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -21.1%
FY 2018 5y median -21.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -37.6%
FY 2018 5y median -24.0% FY 2025
ROIC -35.7%
FY 2018 5y median -25.4% FY 2025
ROA -30.9%
FY 2018 5y median -20.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 18.0%
FY 2018 FY 2025
EPS (diluted) 16.1%
FY 2018 FY 2025
Free Cash Flow 15.2%
FY 2018 FY 2025
Financial Health
Current Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Quick Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31